Your browser doesn't support javascript.
loading
Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma.
Nijland, Marcel; van Meerten, Tom; Seitz, Annika; Huls, Gerwin; Kibbelaar, Robby; Visser, Lydia; van den Berg, Anke; Diepstra, Arjan.
Afiliación
  • Nijland M; Department of Hematology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands. m.nijland@umcg.nl.
  • van Meerten T; Department of Hematology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.
  • Seitz A; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Huls G; Department of Hematology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.
  • Kibbelaar R; Department of Pathology, Pathology Friesland, Leeuwarden, the Netherlands.
  • Visser L; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • van den Berg A; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Ann Hematol ; 97(5): 905-907, 2018 May.
Article en En | MEDLINE | ID: mdl-29327077

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazoles / Linfoma de Células B / Terapia Recuperativa / Inhibidores de Proteínas Quinasas / Janus Quinasa 1 / Janus Quinasa 2 / Terapia Molecular Dirigida / Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazoles / Linfoma de Células B / Terapia Recuperativa / Inhibidores de Proteínas Quinasas / Janus Quinasa 1 / Janus Quinasa 2 / Terapia Molecular Dirigida / Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article